Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

"The enrolment of the first patient in the MAGICAL BTK trial represents an important stride toward improving the standard of ...

"Concept Medical has consistently pursued innovation in vascular therapy," said Dr. Manish Doshi, Founder & Managing Director ...

Concept Medical Inc., a global leader in innovative drug-delivery technology having its state-of-the-art manufacturing facility in Surat has revealed  positive outcomes from the SIRONA (Head-to-Head ...

The investigators analyzed data from the cohort of 1,012 patients recruited to the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) trial. 3 Participants ...

SIRONA trial reveals that sirolimus-coated balloons by Concept Medical match the efficacy of paclitaxel-coated balloons for peripheral artery disease. Conducted in Germany and Austria, the RCT ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Concept Medical Inc. announced the completion of patient enrollment in the SirPAD trial of the company’s MagicTouch percu ...

Concept Medical Inc., announced the enrollment of the first patient in the pivotal MAGICAL BTK randomized controlled trial, whi ...